Evaluation of Safety and Tolerability of ATB-320 in Participants With Progressive or Metastatic Solid Tumors
NCT06933524
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
ATB-320
Sponsor
Autotelicbio